Karyopharm: Phase 1/3 study of selinexor in combo with rux in treatment-naive patients with MF
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Karyopharm Therapeutics
Start Date
October 10, 2023
End Date
October 14, 2028
Administered By
Duke Cancer Institute
Awarded By
Karyopharm Therapeutics
Start Date
October 10, 2023
End Date
October 14, 2028